日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson's Disease

CVN-424:一种用于治疗帕金森病的先进GPR6反向激动剂,目前正处于III期临床试验阶段

Tian, Xiaochen; Ali, Saghir; Allen, John A; Zhou, Jia

DJ-1 alleviates high glucose-induced podocyte injury via activating ERK1/2 signaling

DJ-1通过激活ERK1/2信号通路减轻高糖诱导的足细胞损伤

Tian, Xiaochen; Li, Jing; Han, Tao; Zhang, Leisheng; Lu, Ping; Liu, Yusheng

A Molecularly Defined Medullary Network for Control of Respiratory Homeostasis.

分子定义的髓质网络控制呼吸稳态

Deng Tianjiao, Jing Xinyi, Shao Liuqi, Wang Yakun, Fu Congrui, Yu Hongxiao, Wang Xiaoyi, Zhao Xue, Kong Fanrao, Ji Yake, Tian Xiaochen, He Wei, Bi Shangyu, Shi Luo, Wang Hanqiao, Yuan Fang, Wang Sheng

Asymmetric Catalytic [3 + 3] Annulations of Unmodified Morita-Baylis-Hillman Alcohols to Construct Diverse Heterobicyclic [4.3.0] Skeletons

未修饰的 Morita-Baylis-Hillman 醇的不对称催化 [3 + 3] 环化反应构建多种杂双环 [4.3.0] 骨架

Zhang, Yongxing; Tian, Xiaochen; Wang, Yang

Circ_0074158 and QKI6: A regulatory axis for PD-L1 ubiquitination and immune evasion in NSCLC

Circ_0074158 和 QKI6:非小细胞肺癌中 PD-L1 泛素化和免疫逃逸的调控轴

Haihua Zhang ,Xueying Liu ,Jie Lei ,Feng Tian ,Xiaochen Liu ,Feng Lv ,Shuhong Kang ,Ke Lan ,Jian Wang ,Xiaolong Yan ,Yunfeng Ni

Targeting the 5-HT(2A) Receptor for Developing Psychedelic Drugs and Beyond

靶向5-HT(2A)受体开发迷幻药物及其他

Ali, Saghir; Tian, Xiaochen; Cunningham, Kathryn A; Zhou, Jia

Old Dog, New Tricks: Ibogaine and Its Analogs as Potential Neurotherapeutics

老狗学新招:伊博格碱及其类似物作为潜在的神经治疗药物

Ali, Saghir; Tian, Xiaochen; Cunningham, Kathryn A; Zhou, Jia

A New Era of Artificial Intelligence (AI): Transforming Drug Discovery and Development

人工智能(AI)新时代:变革药物发现与研发

Ali, Saghir; Tian, Xiaochen; Chen, Haiying; Zhou, Jia

Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors

关于工程化NK细胞治疗对免疫检查点抑制剂耐药的肺癌的试验中期报告

Miguel A Villalona-Calero ,Lei Tian ,Xiaochen Li ,Joycelynne M Palmer ,Claudia Aceves ,Hans Meisen ,Catherine Cortez ,Timothy W Synold ,Colt Egelston ,Jeffrey VanDeusen ,Ivone Bruno ,Lei Zhang ,Eliezer Romeu-Bonilla ,Omer Butt ,Stephen J Forman ,Michael A Caligiuri ,Jianhua Yu

Highlights on U.S. FDA-approved halogen-containing drugs in 2024

2024年美国FDA批准的含卤素药物亮点

Ali, Saghir; Tian, Xiaochen; Meccia, Salvatore A; Zhou, Jia